News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
270,110 Results
Type
Article (14348)
Company Profile (281)
Press Release (255481)
Multimedia
Podcasts (49)
Webinars (7)
Section
Business (79855)
Career Advice (159)
Deals (13290)
Drug Delivery (35)
Drug Development (50600)
Employer Resources (32)
FDA (5776)
Job Trends (5155)
News (145034)
Policy (10082)
Tag
Academia (925)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (21755)
ALS (68)
Alzheimer's disease (850)
Antibody-drug conjugate (ADC) (108)
Approvals (5803)
Artificial intelligence (130)
Autoimmune disease (19)
Automation (5)
Bankruptcy (105)
Best Places to Work (4575)
BIOSECURE Act (6)
Biosimilars (44)
Biotechnology (232)
Bladder cancer (59)
Brain cancer (20)
Breast cancer (166)
Cancer (1520)
Cardiovascular disease (120)
Career advice (140)
Career pathing (2)
CAR-T (121)
Cell therapy (337)
Cervical cancer (9)
Clinical research (41260)
Collaboration (555)
Compensation (275)
Complete response letters (13)
COVID-19 (1036)
CRISPR (44)
C-suite (171)
Cystic fibrosis (77)
Data (1598)
Denatured (11)
Depression (32)
Diabetes (142)
Diagnostics (1311)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (10)
Drug discovery (85)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (91)
Earnings (30219)
Editorial (18)
Employer branding (4)
Employer resources (30)
Events (48978)
Executive appointments (470)
FDA (6540)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (509)
Gene editing (102)
Generative AI (10)
Gene therapy (260)
GLP-1 (371)
Government (1089)
Grass and pollen (2)
Guidances (66)
Healthcare (6620)
Huntington's disease (23)
IgA nephropathy (25)
Immunology and inflammation (95)
Indications (21)
Infectious disease (1102)
Inflammatory bowel disease (119)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (68)
Interviews (18)
IPO (7307)
IRA (11)
Job creations (865)
Job search strategy (133)
Kidney cancer (7)
Labor market (8)
Layoffs (215)
Leadership (3)
Legal (1393)
Liver cancer (34)
Lung cancer (207)
Lymphoma (103)
Machine learning (5)
Management (7)
Manufacturing (147)
MASH (59)
Medical device (2622)
Medtech (2623)
Mergers & acquisitions (6324)
Metabolic disorders (402)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (71)
Neuropsychiatric disorders (25)
Neuroscience (1269)
NextGen: Class of 2025 (2026)
Non-profit (858)
Now hiring (22)
Obesity (197)
Opinion (103)
Ovarian cancer (66)
Pain (45)
Pancreatic cancer (60)
Parkinson's disease (121)
Partnered (8)
Patents (136)
Patient recruitment (82)
Peanut (35)
People (25741)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14580)
Phase II (19190)
Phase III (12116)
Pipeline (916)
Policy (47)
Postmarket research (857)
Preclinical (6184)
Press Release (31)
Prostate cancer (63)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (296)
Real estate (1422)
Recruiting (12)
Regulatory (8709)
Reports (17)
Research institute (944)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (62)
Series A (99)
Series B (66)
Service/supplier (1)
Sickle cell disease (41)
Special edition (12)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1982)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (11)
The Weekly (37)
Vaccines (216)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (143)
Last 7 days (543)
Last 30 days (1781)
Last 365 days (19431)
2025 (6901)
2024 (20609)
2023 (22521)
2022 (26922)
2021 (27888)
2020 (23460)
2019 (16309)
2018 (11803)
2017 (13813)
2016 (11916)
2015 (14427)
2014 (10465)
2013 (7543)
2012 (7612)
2011 (7697)
2010 (7522)
Location
Africa (150)
Alabama (43)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17392)
Australia (2950)
California (4038)
Canada (1169)
China (372)
Colorado (152)
Connecticut (154)
Delaware (109)
Europe (37534)
Florida (492)
Georgia (121)
Idaho (16)
Illinois (239)
India (10)
Indiana (94)
Iowa (2)
Japan (78)
Kansas (64)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (492)
Massachusetts (3213)
Michigan (72)
Minnesota (152)
Mississippi (1)
Missouri (25)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (1000)
New Mexico (12)
New York (1078)
North Carolina (568)
North Dakota (5)
Northern California (1800)
Ohio (115)
Oklahoma (9)
Oregon (21)
Pennsylvania (760)
Puerto Rico (6)
Rhode Island (19)
South America (212)
South Carolina (5)
Southern California (1552)
Tennessee (26)
Texas (469)
United States (13792)
Utah (56)
Virginia (84)
Washington D.C. (31)
Washington State (359)
Wisconsin (16)
270,110 Results for "intrinsic therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Intrinsic Therapeutics Names Keith Valentine President and Chief Executive Officer
April 11, 2025
·
3 min read
Press Releases
Peptone Establishes Strategic Partnership with Evotec to Selectively Target Intrinsically Disordered Proteins (IDPs) and Advance Small-Molecule Therapeutics at Scale
May 8, 2025
·
4 min read
Press Releases
Peptone Announces Key Leadership Appointments to Progress Novel Protein Structural Insights for Intrinsically Disordered Protein-Driven Therapeutics
January 10, 2025
·
5 min read
Business
Dave Amerson and Tyler Binney Add Their Experience Commercializing Disruptive Technologies to Intrinsic Therapeutics’ Board of Directors
Intrinsic Therapeutics, Inc. announced the appointment of Dave Amerson and Tyler Binney to its Board of Directors.
February 13, 2024
·
2 min read
Press Releases
Intrinsic Therapeutics Announces Changes in CMS’ 2025 Final Rule for Bone Anchored Annular Closure Resulting in Improved Payment for Hospital Outpatient and ASCs
November 12, 2024
·
2 min read
Press Releases
Intrinsic Therapeutics Announces New Category 1 CPT Code for Bone Anchored Annular Closure, including the Barricaid® Annular Closure Device, to Treat Patients Undergoing Lumbar Discectomy for Herniated Discs
October 25, 2024
·
2 min read
Drug Development
FLAG Therapeutics Announces Encouraging Preclinical Data from Studies of FLAG-003 for the Treatment of Diffuse Intrinsic Pontine Glioma (DIPG)
July 16, 2024
·
4 min read
Genetown
Intrinsic Therapeutics, Inc. Announces Positive Coverage Policy by Cigna Healthcare for Barricaid Bone-Anchored Annular Closure Device
Intrinsic Therapeutics, Inc. announced today that Cigna Healthcare has issued a positive coverage policy for the Barricaid® Bone-Anchored Annular Closure device.
June 21, 2023
·
2 min read
Genetown
Intrinsic Therapeutics Announces Results from Post Market Study Confirming Benefits of Barricaid® Annular Closure Implant
Intrinsic Therapeutics, Inc. today has announced the publication of results from a post-market study that the use of Barricaid in high-risk patients results in significantly fewer reherniations and reoperations when compared to patients treated with discectomy alone.
June 28, 2023
·
3 min read
FDA
Kintara Therapeutics Receives Orphan Drug Designation for VAL-083 for Treatment of Diffuse Intrinsic Pontine Glioma (DIPG)
Kintara Therapeutics, Inc. today announced it has received Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA) for VAL-083 for the treatment of diffuse intrinsic pontine glioma (DIPG), a rare and highly-aggressive childhood brain cancer.
December 15, 2022
·
4 min read
1 of 27,011
Next
